Company Name
XBiotech Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN:
CA98400H1029
CIK:
0001626878
CUSIP:
98400H102
Currency:
USD
Full Time Employees:
87
Phone:
512 386 2900
Website:
https://www.xbiotech.com
Fiscal Year End:
December
IPO Date:
Apr 15, 2015
Description:
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
Address:
5217 Winnebago Lane, Austin, TX, United States, 78744